Methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate

Methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate is a specialized heterocyclic intermediate is used mainly as an intermediate in the synthesis of fexuprazan, a novel potassium-competitive acid blocker for treating gastroesophageal reflux disease (GERD)

API Name Abeprazan hydrochloride
CAS No 1902955-29-6
Molecular Formula C13H11F2NO3
Molecular Weight 267.23 g/mol
Synonyms methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate